rs2229432

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_000208.4(INSR):​c.2643C>T​(p.Ile881Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00931 in 1,614,070 control chromosomes in the GnomAD database, including 163 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 49 hom., cov: 31)
Exomes 𝑓: 0.0084 ( 114 hom. )

Consequence

INSR
NM_000208.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.12

Publications

7 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 19-7141716-G-A is Benign according to our data. Variant chr19-7141716-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 330453.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.12 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0184 (2808/152274) while in subpopulation AFR AF = 0.0437 (1818/41564). AF 95% confidence interval is 0.0421. There are 49 homozygotes in GnomAd4. There are 1369 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 49 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INSRNM_000208.4 linkc.2643C>T p.Ile881Ile synonymous_variant Exon 13 of 22 ENST00000302850.10 NP_000199.2 P06213-1
INSRNM_001079817.3 linkc.2607C>T p.Ile869Ile synonymous_variant Exon 12 of 21 NP_001073285.1 P06213-2
INSRXM_011527988.3 linkc.2643C>T p.Ile881Ile synonymous_variant Exon 13 of 22 XP_011526290.2
INSRXM_011527989.4 linkc.2607C>T p.Ile869Ile synonymous_variant Exon 12 of 21 XP_011526291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INSRENST00000302850.10 linkc.2643C>T p.Ile881Ile synonymous_variant Exon 13 of 22 1 NM_000208.4 ENSP00000303830.4 P06213-1
INSRENST00000341500.9 linkc.2607C>T p.Ile869Ile synonymous_variant Exon 12 of 21 1 ENSP00000342838.4 P06213-2
INSRENST00000597211.1 linkn.326C>T non_coding_transcript_exon_variant Exon 2 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.0183
AC:
2792
AN:
152156
Hom.:
48
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0434
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.00720
Gnomad ASJ
AF:
0.0153
Gnomad EAS
AF:
0.0417
Gnomad SAS
AF:
0.00415
Gnomad FIN
AF:
0.00960
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00664
Gnomad OTH
AF:
0.0163
GnomAD2 exomes
AF:
0.0113
AC:
2837
AN:
251482
AF XY:
0.0100
show subpopulations
Gnomad AFR exome
AF:
0.0457
Gnomad AMR exome
AF:
0.00437
Gnomad ASJ exome
AF:
0.0118
Gnomad EAS exome
AF:
0.0391
Gnomad FIN exome
AF:
0.0101
Gnomad NFE exome
AF:
0.00672
Gnomad OTH exome
AF:
0.00978
GnomAD4 exome
AF:
0.00836
AC:
12215
AN:
1461796
Hom.:
114
Cov.:
31
AF XY:
0.00796
AC XY:
5786
AN XY:
727200
show subpopulations
African (AFR)
AF:
0.0427
AC:
1428
AN:
33478
American (AMR)
AF:
0.00467
AC:
209
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0130
AC:
341
AN:
26136
East Asian (EAS)
AF:
0.0418
AC:
1658
AN:
39700
South Asian (SAS)
AF:
0.00223
AC:
192
AN:
86254
European-Finnish (FIN)
AF:
0.0105
AC:
562
AN:
53418
Middle Eastern (MID)
AF:
0.00971
AC:
56
AN:
5768
European-Non Finnish (NFE)
AF:
0.00640
AC:
7113
AN:
1111924
Other (OTH)
AF:
0.0109
AC:
656
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
705
1410
2115
2820
3525
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
324
648
972
1296
1620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0184
AC:
2808
AN:
152274
Hom.:
49
Cov.:
31
AF XY:
0.0184
AC XY:
1369
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0437
AC:
1818
AN:
41564
American (AMR)
AF:
0.00719
AC:
110
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0153
AC:
53
AN:
3472
East Asian (EAS)
AF:
0.0415
AC:
214
AN:
5162
South Asian (SAS)
AF:
0.00415
AC:
20
AN:
4820
European-Finnish (FIN)
AF:
0.00960
AC:
102
AN:
10622
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00664
AC:
452
AN:
68028
Other (OTH)
AF:
0.0161
AC:
34
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
136
272
409
545
681
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0114
Hom.:
16
Bravo
AF:
0.0200
Asia WGS
AF:
0.0230
AC:
80
AN:
3478
EpiCase
AF:
0.00523
EpiControl
AF:
0.00510

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Insulin-resistant diabetes mellitus AND acanthosis nigricans Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Rabson-Mendenhall syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Hyperinsulinism due to INSR deficiency Benign:1
-
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

Potent mutations in INSR gene can lead to insulin resistance, which presents as impaired glucose tolerance, early onset type 2 diabetes, post prandial hyperglycemia and increased insulin requirement in type 1 diabetes. These mutations in INSR gene can also predispose to coronary artery disease, metabolic syndrome, polycystic ovarian disease and non alcoholic fatty liver disease.However, the role of this particular variant rs2229432 with early onset diabetes mellitus is yet to be ascertained. -

Leprechaunism syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
CADD
Benign
0.35
DANN
Benign
0.78
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229432; hg19: chr19-7141727; COSMIC: COSV57164935; API